ArticleInternational journal of molecular sciences2023

GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.

Kelsey E Huntington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.